These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36310242)

  • 1. Effects of prophylactic indomethacin on morbidity and mortality in infants <25 weeks' gestation: a protocol driven intention to treat analysis.
    Clyman RI; Hills NK
    J Perinatol; 2022 Dec; 42(12):1662-1668. PubMed ID: 36310242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes.
    Liebowitz M; Clyman RI
    J Pediatr; 2017 Aug; 187():119-126.e1. PubMed ID: 28396025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic indomethacin and the risk of serious pulmonary hemorrhages in preterm infants less than 28 weeks' gestation.
    Clyman RI; Hills NK
    J Perinatol; 2024 Oct; 44(10):1470-1477. PubMed ID: 38658692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Prophylactic Indomethacin on Vasopressor-Dependent Hypotension in Extremely Preterm Infants.
    Liebowitz M; Koo J; Wickremasinghe A; Allen IE; Clyman RI
    J Pediatr; 2017 Mar; 182():21-27.e2. PubMed ID: 27915200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized Noninferiority Trial of Expectant Management versus Early Treatment of Patent Ductus Arteriosus in Preterm Infants.
    Potsiurko S; Dobryanskyy D; Sekretar L; Salabay Z
    Am J Perinatol; 2024 Apr; 41(6):730-738. PubMed ID: 35213904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indomethacin for symptomatic patent ductus arteriosus in preterm infants.
    Evans P; O'Reilly D; Flyer JN; Soll R; Mitra S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013133. PubMed ID: 33448032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic indomethacin, antenatal betamethasone, and the risk of intestinal perforation in infants <28 weeks' gestation.
    Clyman RI; Hills NK
    J Perinatol; 2023 Oct; 43(10):1252-1261. PubMed ID: 36973384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.
    Mitra S; Scrivens A; von Kursell AM; Disher T
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013278. PubMed ID: 33301630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants.
    Mosalli R; Alfaleh K
    Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD006181. PubMed ID: 18254095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004213. PubMed ID: 31985838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants.
    Gudmundsdottir A; Johansson S; Håkansson S; Norman M; Källen K; Bonamy AK
    Neonatology; 2015; 107(2):87-92. PubMed ID: 25412681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic indomethacin reduces grades III and IV intraventricular hemorrhages when compared to early indomethacin treatment of a patent ductus arteriosus.
    Yanowitz TD; Baker RW; Sobchak Brozanski B
    J Perinatol; 2003 Jun; 23(4):317-22. PubMed ID: 12774141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Patent Ductus Arteriosus Treatment Strategy and Respiratory Outcomes in Premature Infants.
    Relangi D; Somashekar S; Jain D; Vanbuskirk S; Bancalari E; Sosenko I; Claure N
    J Pediatr; 2021 Aug; 235():58-62. PubMed ID: 33894266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mandatory Closure Versus Nonintervention for Patent Ductus Arteriosus in Very Preterm Infants.
    Sung SI; Chang YS; Chun JY; Yoon SA; Yoo HS; Ahn SY; Park WS
    J Pediatr; 2016 Oct; 177():66-71.e1. PubMed ID: 27453374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age.
    Clyman RI; Liebowitz M; Kaempf J; Erdeve O; Bulbul A; Håkansson S; Lindqvist J; Farooqi A; Katheria A; Sauberan J; Singh J; Nelson K; Wickremasinghe A; Dong L; Hassinger DC; Aucott SW; Hayashi M; Heuchan AM; Carey WA; Derrick M; Fernandez E; Sankar M; Leone T; Perez J; Serize A;
    J Pediatr; 2019 Feb; 205():41-48.e6. PubMed ID: 30340932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Neonatal Outcomes With and Without Prophylaxis With Indomethacin in Premature Neonates.
    Pan I; Shah PA; Singh J; Kelly KN; Bondi DS
    J Pediatr Pharmacol Ther; 2021; 26(5):478-483. PubMed ID: 34239400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between Duration of Infant Exposure to a Moderate-to-Large Patent Ductus Arteriosus Shunt and the Risk of Developing Bronchopulmonary Dysplasia or Death Before 36 Weeks.
    Clyman RI; Hills NK; Liebowitz M; Johng S
    Am J Perinatol; 2020 Jan; 37(2):216-223. PubMed ID: 31600791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews.
    Mitra S; de Boode WP; Weisz DE; Shah PS
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013588. PubMed ID: 37039501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic indomethacin in extremely premature infants between 23 and 24 weeks gestation.
    Yoshimoto S; Sakai H; Ueda M; Yoshikata M; Mizobuchi M; Nakao H
    Pediatr Int; 2010 Jun; 52(3):374-7. PubMed ID: 19843236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias.
    Mirea L; Sankaran K; Seshia M; Ohlsson A; Allen AC; Aziz K; Lee SK; Shah PS;
    J Pediatr; 2012 Oct; 161(4):689-94.e1. PubMed ID: 22703954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.